MANAGEMENT OF ALLERGIC CONJUNCTIVITIS WITH MADHUKADI VIDALAKA

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF MADHUKADI VIDALAKA IN THE MANAGEMENT OF VATAJAABHISHYANDA W.S.R. TO ALLERGIC CONJUNCTIVITIS

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/03/017900

Enrollment

Registered

2019-03-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H101- Acute atopic conjunctivitis

Interventions

Intervention1: MADHUKADI VIDALAKA: Patient treating with Madhukadi Vidalaka as topical application over the outer surface of eye lid except eye lashes, dose- 1-2gm/ seating ,twice daily for 7 days. In

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients presenting with signs and symptoms of Vataja Abhishyanda as mentioned in classical text. 2.patient presenting with signs and symptoms of Allergic Conjunctivitis.

Exclusion criteria

Exclusion criteria: 1.Patients having complicated eye diseases and trachoma, chalazion, stye, pterygium, etc. 2.Patients suffering from corneal opacity, ulcers. 3.Patients suffering from uncontrolled systemic disease like HTN and DM, TB etc.

Design outcomes

Primary

Measure	Time frame
Relive the symptoms like Eyelid edema, Redness of eye,Bilateral ocular itching.Timepoint: 7 Days	—

Secondary

Measure	Time frame
Relive the symptoms like Watering of eye, Foreign body sensation,Photo phobia etc.Timepoint: 7-10 Days	—

Countries

India

Contacts

Public ContactSufiya Mahetabkhan Pathan

Parul institute of Ayurveda

drdsdave54@gmail.com9423847252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026